查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1807613

手術縫合線市場（按材料、生物分解性、長絲、應用和最終用戶）—2025-2030 年全球預測

Surgical Suture Market by Material, Biodegradability, Filament, Application, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計手術縫線市場規模在 2024 年將達到 50.8 億美元，2025 年將達到 53.8 億美元，到 2030 年將達到 70.7 億美元，複合年成長率為 5.66%。

主要市場統計數據
基準年2024年 50.8億美元
預計2025年 53.8億美元
預測年份 2030 70.7億美元
複合年成長率（%） 5.66%

為全面研究影響全球醫療保健的手術縫合創新和市場動態奠定基礎

外科縫合線市場透過傷口縫合技術影響癒合軌跡和病患安全，在改善全球醫療保健結果方面發揮關鍵作用。縫合線是外科手術的基本組成部分，在提供機械支撐的同時，最大限度地降低感染風險，並促進最佳組織再生。隨著手術日益複雜和患者群體老化，對創新縫合解決方案的需求日益成長。

揭示關鍵的技術、監管和臨床進展，重新定義整個醫療生態系統的手術縫合市場格局

由於技術創新的快速發展、法律規範的不斷演變以及臨床應用的不斷變化，外科縫合線產業正在經歷重大變革時期。生物活性塗層、藥物釋放型線絲以及新一代可吸收聚合物等創新技術正在重新定義傷口縫合的有效性。因此，製造商正在大力投入研發，力求將抗菌特性和控制釋放療法直接融入縫線基質，從而減少術後併發症並加速患者復健。

評估2025年美國新關稅對供應鏈、定價結構和產業競爭的深遠影響

2025年美國新關稅的實施將給依賴進口原料和成品縫合線的公司帶來巨大的成本挑戰。尤其是特殊聚合物和鈷基針頭合金關稅的提高，將對整個供應鏈產生連鎖反應，促使製造商重新評估籌資策略。因此，許多組織正在探索與本地製造商的合作，以降低進口成本並保持具有競爭力的價格。

揭示材料成分、生物分解性特性、長絲結構、臨床應用和最終用戶環境的關鍵見解，以指導市場策略

透過材料成分分析市場，可以發現天然纖維和合成纖維的性能差異。天然纖維具有更高的生物相容性，尤其適用於精細手術；而合成聚合物則具有穩定的拉伸強度和可預測的吸收率。因此，這兩類材料之間的選擇取決於手術要求和外科醫生的偏好。

分析美洲、歐洲、中東和非洲以及亞太地區的區域表現和成長動力，揭示獨特的市場動態和戰略驅動力

不同的醫療基礎設施、法規環境和創新生態系統決定了不同地區對手術縫合線需求的差異。在美洲，強大的報銷框架、良好的醫院網路以及強勁的國內製造能力，為先進縫合技術的持續應用提供了支援。此外，積極的公私合作研究計畫正在強化產品平臺，並加速臨床檢驗。

介紹領先的手術縫合線製造商，其有效的策略和策略聯盟推動了動態醫療保健市場的創新、擴充性和競爭差異化

外科縫合領域的主要參與企業已利用研發方面的策略投資來建立競爭優勢。老牌醫療設備集團透過有針對性地收購專注於可吸收聚合物和抗菌塗層的利基生物技術創新公司，擴大了其產品組合，從而保持了廣泛的產品系列，以滿足不同的臨床需求和價格分佈。

提供策略建議，以推動創新管道、加強供應鏈並增強臨床夥伴關係模式，實現永續成長

產業領導者應優先考慮整合兼具機械強度、抗菌和藥物傳遞功能的多功能生醫材料。投資模組化研發框架可以加速產品的迭代改進，並支援在不斷變化的監管標準下進行快速測試。此外，與臨床研究機構建立夥伴關係，可以促進下一代絲材在實際手術環境中的早期檢驗。

結合次要分析、專家訪談和資料三角測量的全面、多階段調查方法確保了分析的嚴謹性

本分析基於嚴格的多階段調查方法，旨在確保數據可靠性和對外科縫合線市場的全面覆蓋。首先，對同行評審日誌、監管文件和行業出版物進行了廣泛的二次審查，建立了對技術趨勢、材料科學進展和政策發展的基礎了解。

總結關鍵發現和策略意義，為相關人員提供外科縫線投資、開發和競爭差異化的明確方向

總而言之，外科縫線市場正處於一個關鍵的曲折點，技術創新、監管變革和供應鏈重組正在交匯，重新定義競爭格局。材料進步和多功能線材設計正在開啟新的臨床應用可能性，而關稅的實施凸顯了多元化採購和區域製造策略的必要性。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 腹腔鏡和機器人手術中擴大採用倒鉤縫合線，提高了手術效率和患者預後
  • 關注抗菌縫合塗層，降低高風險手術患者術後感染率
  • 開發生物可吸收水凝膠縫合材料以促進組織再生並減少疤痕形成
  • 將智慧縫合技術與生物感測器結合，實現即時傷口監測和感染檢測
  • 人們對無結縫合器械的需求日益成長，因為這種器械可以方便地進行微創和內視鏡手術，並能安全地進入組織。
  • 結合止血和抗菌特性的多功能縫合塗層在複雜傷口處理的應用進展
  • 利用組織黏附微球進行縫合擴張，以促進止血並促進創傷護理中傷口縫合
  • 用於加速藥物傳輸和將治療劑定向釋放到傷口部位的奈米工程縫合纖維的研究正在蓬勃發展
  • 轉向環保縫合線包裝和生物分解性材料，以減少醫療廢棄物和碳排放
  • 加強縫合線製造商與生技公司的合作，開發適合患者基因組的個人化再生縫合線解決方案

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第 8 章：外科縫線市場（按材料）

  • 自然的
  • 合成

9. 外科縫合線市場（依生物分解）

  • 吸收性
  • 不可吸收

第10章手術縫合線市場

  • 單絲
  • 多絲纖維

第 11 章。按應用分類的手術縫合線市場

  • 心血管手術
    • 冠狀動脈繞道手術手術（CABG）
    • 心臟瓣膜修復/置換
  • 一般外科
  • 神經外科
  • 眼科手術
    • 白內障手術
    • 角膜移植
  • 整形外科
    • 關節鏡
    • 骨折固定和韌帶修復
    • 關節重建
  • 整形外科/重組外科
    • 乳房重建
    • 整容手術

第 12 章 手術縫線市場（依最終使用者）

  • 門診手術中心（ASC）
  • 診所
  • 醫院
  • 研究和學術機構

13.美洲外科縫合線市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14.歐洲、中東和非洲手術縫線市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

15.亞太外科縫合線市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第16章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Advanced Medical Solutions Group plc
    • B. Braun SE
    • CONMED Corporation
    • DemeTECH Corporation
    • Healthium Medtech Ltd.
    • Johnson & Johnson Services, Inc.
    • Lotus Surgicals Pvt Ltd
    • Medtronic PLC
    • Mellon Medical BV
    • Smith & Nephew PLC
    • Stryker Corporation
    • Corza Medical GmbH
    • Unisur Lifecare Pvt. Ltd.
    • Zimmer Biomet Holdings, Inc.
    • Teleflex Incorporated
    • GMD Group
    • Atramat by Internacional Farmaceutica SA . de CV
    • Shandong Haidike Medical Products Co.,Ltd.
    • Demophorius Healthcare Ltd.
    • AIP Medical SA
    • Vitrex Medical A/S
    • Lux Sutures SA
    • Sutumed Corp.
    • Centenial Surgical Suture Ltd.
    • Orion Sutures India Pvt Ltd
    • Dolphin Sutures
    • AD Surgical
    • McKesson Medical-Surgical Inc.
    • SUTUREGARD Medical, Inc.
    • Genesis Medtech
    • Lydus Medical
    • Riverpoint Medical
    • Able Medical Devices Inc.

第17章 研究人工智慧

第18章 研究統計

第19章 研究聯絡人

第20章 研究報導

第21章 附錄

Product Code: MRR-FD3F12D52777

The Surgical Suture Market was valued at USD 5.08 billion in 2024 and is projected to grow to USD 5.38 billion in 2025, with a CAGR of 5.66%, reaching USD 7.07 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 5.08 billion
Estimated Year [2025] USD 5.38 billion
Forecast Year [2030] USD 7.07 billion
CAGR (%) 5.66%

Setting the Stage for a Comprehensive Exploration of Surgical Suture Innovations and Market Dynamics Impacting Global Healthcare

The surgical suture market plays a pivotal role in advancing global healthcare outcomes through wound closure techniques that influence healing trajectories and patient safety. Sutures form a foundational component of surgical practice, providing mechanical support while minimizing infection risk and promoting optimal tissue regeneration. As procedures grow increasingly complex and patient populations age, the demand for innovative suture solutions continues to intensify.

This executive summary delivers a comprehensive overview of the key trends, regulatory shifts, and competitive dynamics shaping the surgical suture landscape. It synthesizes insights across material innovations, biodegradability considerations, filament technologies, application domains, and end-user channels to guide decision-makers in aligning their strategies with emerging market realities. Furthermore, it examines the implications of recent policy changes, including the introduction of new tariffs, which are poised to influence cost structures and supply chain resilience.

Drawing upon expert interviews, secondary research, and rigorous data validation, this summary offers a concise yet thorough narrative designed to inform stakeholders in device manufacturing, clinical practice, investment, and policy development. By navigating through transformative shifts, segmentation analyses, regional nuances, and competitive positioning, readers will gain an integrated perspective to drive informed action and sustained growth in the surgical suture sector.

Unveiling the Pivotal Technological, Regulatory, and Clinical Advancements Redefining the Surgical Suture Market Landscape Across the Healthcare Ecosystem

The surgical suture industry is undergoing a period of profound transformation driven by rapid technological breakthroughs, evolving regulatory frameworks, and shifting clinical practices. Innovations such as bioactive coatings, drug-eluting filaments, and next-generation absorbable polymers are redefining the parameters of wound closure efficacy. Consequently, manufacturers are investing heavily in research to integrate antimicrobial properties and controlled-release therapeutics directly into suture matrices, thereby reducing postoperative complications and expediting patient recovery.

Simultaneously, regulatory bodies are tightening quality and safety standards, mandating enhanced traceability and rigorous performance testing. This trend has accelerated the adoption of digital tracking systems and advanced sterilization protocols, ensuring that sutures meet the stringent demands of global healthcare providers. Moreover, the rise of minimally invasive and robotic-assisted surgical techniques has heightened the need for precision-engineered filaments capable of navigating delicate anatomical structures.

In parallel, sustainability considerations have prompted a shift toward eco-friendly materials that address the environmental impact of synthetic polymers. Biodegradable options are gaining traction among clinicians seeking to balance performance with ecological responsibility. As a result, the confluence of clinical, regulatory, and environmental drivers is setting new benchmarks for product development, compelling industry participants to adapt swiftly or risk obsolescence.

Assessing the Far-Reaching Effects of Newly Implemented United States Tariffs in 2025 on Supply Chains, Pricing Structures, and Industry Competitiveness

The implementation of new United States tariffs in 2025 has introduced significant cost challenges for companies reliant on imported raw materials and finished suture products. In particular, higher duties on specialized polymers and cobalt-based needle alloys have reverberated through supply chains, prompting manufacturers to reassess their sourcing strategies. As a result, many organizations are exploring localized production partnerships to mitigate import expenses and maintain competitive pricing structures.

Moreover, distributors and healthcare providers have felt the impact through elevated procurement costs, which have necessitated renegotiations of supply contracts and spurred interest in alternative filament technologies that are exempt from the newest tariff classifications. Consequently, synthetic polymer suppliers within the U.S. have seen heightened demand, leveraging their domestic footprint to offer expedited fulfillment and reduced duty burdens.

However, this recalibration has not been without its trade-offs. Transitioning to alternative suppliers often entails extended lead times and additional validation processes, introducing potential risks to inventory continuity. To that end, industry participants are investing in dual-sourcing models and strategic stockpiling to safeguard against supply disruptions. In sum, the 2025 tariff adjustments have accentuated the importance of supply chain agility and cost management as critical success factors in the surgical suture market.

Illuminating Critical Insights Across Material Composition, Biodegradability Profiles, Filament Architectures, Clinical Applications, and End-User Environments to Guide Market Strategies

Analyzing the market through the lens of material composition reveals divergent performance profiles between natural and synthetic sutures. Natural fibers offer biocompatibility advantages, particularly in delicate procedures, whereas synthetic polymers deliver consistent tensile strength and predictable absorption rates. Consequently, the choice between these two categories hinges on procedural requirements and surgeon preferences.

Turning to biodegradability, absorbable sutures have gained prominence in scenarios where secondary removal procedures pose additional risk, while non-absorbable filaments persist in applications demanding prolonged mechanical support, such as cardiovascular anastomoses. This distinction shapes product development priorities and inventory management protocols across healthcare institutions.

Examining filament structure, monofilament designs minimize tissue drag and reduce infection risk, making them preferable for skin closures and urologic repairs. In contrast, multifilament constructs enhance knot security and pliability, which supports their adoption in gastrointestinal and orthopedic surgeries. The interplay between filament type and clinical context informs surgeon selection and procurement strategies.

When considering the application spectrum, sutures tailored for cardiac surgery must accommodate coronary artery bypass grafting and heart valve repair with precision, while ophthalmic options address cataract surgery and corneal transplantation through ultra-fine gauge materials. Orthopedic use cases range from arthroscopy to fracture fixation and joint replacement, demanding robust tensile performance. Plastic and reconstructive procedures, encompassing breast reconstruction and cosmetic enhancements, prioritize both structural integrity and aesthetic outcomes.

Finally, end-user dynamics span ambulatory surgical centers seeking cost-effective, streamlined solutions; clinics requiring ready-to-use kits; hospitals demanding broad product portfolios; and research and academic institutes focused on experimental biomaterials. This multifaceted segmentation underscores the necessity for customized offerings that align with the distinct priorities of each customer group.

Dissecting Regional Performance and Growth Drivers Within the Americas, Europe Middle East & Africa, and Asia Pacific to Reveal Unique Market Dynamics and Strategic Imperatives

Regional variations in surgical suture demand are shaped by distinct healthcare infrastructures, regulatory environments, and innovation ecosystems. Within the Americas, strong reimbursement frameworks, established hospital networks, and robust domestic manufacturing capabilities drive sustained adoption of advanced suture technologies. Furthermore, proactive public-private collaborations in research initiatives bolster product pipelines and accelerate clinical validation.

In contrast, Europe, Middle East & Africa presents a mosaic of regulatory standards and procurement practices. While Western European markets prioritize high-performance, bioactive sutures supported by extensive clinical data, emerging markets in the Middle East and Africa are increasingly investing in capacity-building to meet rising surgical volumes. Collaborative efforts to harmonize standards and streamline approval processes are elevating regional competitiveness.

Meanwhile, the Asia-Pacific region has emerged as a powerhouse for both production and consumption. Rapid healthcare modernization, growing surgical volumes, and expanding medical tourism have fueled demand for cost-effective yet innovative suture solutions. Local manufacturers are scaling up capabilities to supply both domestic and export markets, while multinational corporations forge partnerships to navigate diverse regulatory frameworks and leverage distribution networks.

Together, these regional insights highlight the importance of tailoring market entry and growth strategies to align with localized regulatory landscapes, clinical practices, and supply chain considerations. By recognizing the nuanced drivers within each geography, companies can optimize product positioning and resource allocation to capture emerging opportunities.

Profiling Leading Surgical Suture Manufacturers and Their Strategic Collaborations Fueling Innovation, Scalability, and Competitive Differentiation in a Dynamic Healthcare Market

Leading participants in the surgical suture domain have leveraged strategic investments in research and development to establish competitive moats. Established medical device conglomerates have expanded their portfolios through targeted acquisitions of niche biotech innovators specializing in absorbable polymers and antimicrobial coatings. As a result, they maintain a broad product range that addresses diverse clinical requirements and price points.

At the same time, specialized manufacturers have distinguished themselves by focusing on next-generation biomaterials, such as bioresorbable copolymers and drug-infused filaments, enabling them to capture share in high-growth segments. Through collaborations with academic research centers, these companies benefit from early access to experimental data and can accelerate product commercialization timelines.

Distribution partners have also played a pivotal role by integrating digital procurement platforms, which provide real-time visibility into stock levels, usage trends, and performance outcomes. These systems enhance decision support for healthcare providers and reinforce supplier relationships.

Additionally, alliances between device producers and contract manufacturing organizations have streamlined scale-up processes, reducing time to market for innovative offerings. By combining technological expertise with manufacturing agility, these partnerships enable rapid response to shifting clinical demands and emerging tariff constraints.

Overall, the market's competitive landscape is defined by the interplay between legacy manufacturers, agile niche players, and value-added distributors, each contributing to a dynamic environment of continuous innovation and strategic repositioning.

Delivering Strategic Recommendations to Drive Innovation Pipelines, Strengthen Supply Chain Resilience, and Enhance Clinical Partnership Models for Sustainable Growth

Industry leaders should prioritize the integration of multifunctional biomaterials that combine mechanical strength with antimicrobial and drug-delivery capabilities. Investing in modular R&D frameworks will accelerate iterative product enhancements and support rapid testing under evolving regulatory standards. Moreover, cultivating partnerships with clinical research institutions can facilitate early validation of next-generation filaments in real-world surgical settings.

In light of supply chain uncertainties accentuated by new tariffs, organizations must develop dual-sourcing strategies and evaluate regional manufacturing alliances to secure material access and mitigate cost volatility. Establishing strategic stock reserves and leveraging contract manufacturing relationships will enhance agility and maintain continuity of supply.

Furthermore, enhancing digital engagement with healthcare providers through integrated procurement and performance-tracking platforms will yield actionable usage data. This intelligence can inform targeted marketing efforts, optimize product mix, and strengthen customer loyalty by demonstrating clinical value in quantifiable terms.

To capture emerging opportunities in high-growth applications, firms should tailor their portfolio to address specialized procedures such as robotic-assisted minimally invasive surgeries and reconstructive interventions. Customizing suture solutions for these niches will position companies as preferred partners for advanced surgical care.

Finally, embedding sustainability targets into product development roadmaps-by reducing environmental impact of polymers and packaging-will align with global healthcare sustainability mandates and resonate with environmentally conscious stakeholders.

Detailing a Comprehensive Multistage Research Methodology Blending Secondary Analysis, Expert Interviews, and Data Triangulation to Ensure Analytical Rigor

This analysis is grounded in a rigorous, multistage research methodology designed to ensure data reliability and comprehensive coverage of the surgical suture market. Initially, an extensive secondary review of peer-reviewed journals, regulatory filings, and industry publications established baseline understanding of technological trends, material science advances, and policy developments.

Subsequently, primary interviews were conducted with a cross-section of stakeholders, including senior executives from leading medical device manufacturers, procurement leaders at major healthcare systems, and key opinion leaders specializing in surgical practice. These in-depth conversations provided nuanced perspectives on clinical requirements, unmet needs, and adoption barriers.

Quantitative data was triangulated through data validation protocols, comparing trade statistics, patent filings, and public financial disclosures to ensure consistency and accuracy. Advanced analytical models were then applied to identify correlations between segmentation variables and market dynamics.

Throughout the research process, iterative quality checks and peer reviews were implemented to uphold methodological rigor. This robust approach combines qualitative insights with empirical evidence, furnishing a solid foundation for the strategic findings and recommendations presented in this summary.

Summarizing Core Findings and Strategic Implications to Empower Stakeholders With Clear Directions for Investment, Development, and Competitive Differentiation in Surgical Sutures

In conclusion, the surgical suture market stands at a critical inflection point where technological innovation, regulatory evolution, and supply chain realignment converge to redefine competitive landscapes. Material advancements and multifunctional filament designs are unlocking new clinical possibilities, while the introduction of tariffs has underscored the necessity of diversified sourcing and regional manufacturing strategies.

Segmentation insights reveal that customizing suture solutions across material types, biodegradability profiles, filament structures, application areas, and end-user channels is paramount to meeting diverse clinical demands. Regional intelligence highlights that strategic market entries must consider localized regulatory requirements and distribution paradigms to maximize impact.

Key players are forging strategic alliances, investing in digital procurement platforms, and expanding their portfolios through targeted acquisitions to maintain market leadership. Industry stakeholders must respond by aligning innovation roadmaps with emerging procedural trends, reinforcing supply chain flexibility, and embedding sustainability into their core strategies.

By synthesizing these insights and recommendations, decision-makers are equipped with a clear blueprint to navigate the unfolding opportunities and challenges of the surgical suture arena, driving sustained value creation and improved patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Rising adoption of barbed sutures for laparoscopic and robotic surgical procedures improving operative efficiency and patient outcomes
  • 5.2. Increased focus on antimicrobial suture coatings to reduce postoperative infection rates in high-risk surgical patients
  • 5.3. Development of bioabsorbable hydrogel-based suture materials for enhanced tissue regeneration and reduced scar formation
  • 5.4. Integration of smart suture technologies with biosensors for real-time wound monitoring and infection detection
  • 5.5. Growing demand for knotless suture devices facilitating minimally invasive and endoscopic surgeries with secure tissue approximation
  • 5.6. Advancements in multifunctional suture coatings combining hemostatic and antimicrobial properties for complex wound management
  • 5.7. Expansion of sutures with tissue adhesive microspheres to accelerate hemostasis and promote faster wound closure in trauma care
  • 5.8. Surge in research on nano-engineered suture fibers for accelerated drug delivery and targeted therapeutic release at wound sites
  • 5.9. Shift towards environmentally sustainable suture packaging and biodegradable materials to reduce medical waste and carbon footprint
  • 5.10. Increased collaboration between suture manufacturers and biotech firms to develop personalized regenerative suture solutions tailored to patient genomics

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Surgical Suture Market, by Material

  • 8.1. Introduction
  • 8.2. Natural
  • 8.3. Synthetic

9. Surgical Suture Market, by Biodegradability

  • 9.1. Introduction
  • 9.2. Absorbable
  • 9.3. Non Absorbable

10. Surgical Suture Market, by Filament

  • 10.1. Introduction
  • 10.2. Monofilament
  • 10.3. Multifilament

11. Surgical Suture Market, by Application

  • 11.1. Introduction
  • 11.2. Cardiac Surgery
    • 11.2.1. Coronary Artery Bypass Grafting (CABG)
    • 11.2.2. Heart Valve Repair/Replacement
  • 11.3. General Surgery
  • 11.4. Neurological Surgery
  • 11.5. Ophthalmic Surgery
    • 11.5.1. Cataract Surgery
    • 11.5.2. Corneal Transplantation
  • 11.6. Orthopedic Surgery
    • 11.6.1. Arthroscopy
    • 11.6.2. Fracture Fixation & Ligament Repair
    • 11.6.3. Joint Replacement
  • 11.7. Plastic & Reconstructive Surgery
    • 11.7.1. Breast Reconstruction
    • 11.7.2. Cosmetic Procedures

12. Surgical Suture Market, by End-user

  • 12.1. Introduction
  • 12.2. Ambulatory Surgical Centers (ASCs)
  • 12.3. Clinics
  • 12.4. Hospitals
  • 12.5. Research & Academic Institutes

13. Americas Surgical Suture Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Surgical Suture Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Surgical Suture Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Advanced Medical Solutions Group plc
    • 16.3.2. B. Braun SE
    • 16.3.3. CONMED Corporation
    • 16.3.4. DemeTECH Corporation
    • 16.3.5. Healthium Medtech Ltd.
    • 16.3.6. Johnson & Johnson Services, Inc.
    • 16.3.7. Lotus Surgicals Pvt Ltd
    • 16.3.8. Medtronic PLC
    • 16.3.9. Mellon Medical B.V.
    • 16.3.10. Smith & Nephew PLC
    • 16.3.11. Stryker Corporation
    • 16.3.12. Corza Medical GmbH
    • 16.3.13. Unisur Lifecare Pvt. Ltd.
    • 16.3.14. Zimmer Biomet Holdings, Inc.
    • 16.3.15. Teleflex Incorporated
    • 16.3.16. GMD Group
    • 16.3.17. Atramat by Internacional Farmaceutica S.A . de C.V.
    • 16.3.18. Shandong Haidike Medical Products Co.,Ltd.
    • 16.3.19. Demophorius Healthcare Ltd.
    • 16.3.20. AIP Medical SA
    • 16.3.21. Vitrex Medical A/S
    • 16.3.22. Lux Sutures SA
    • 16.3.23. Sutumed Corp.
    • 16.3.24. Centenial Surgical Suture Ltd.
    • 16.3.25. Orion Sutures India Pvt Ltd
    • 16.3.26. Dolphin Sutures
    • 16.3.27. AD Surgical
    • 16.3.28. McKesson Medical-Surgical Inc.
    • 16.3.29. SUTUREGARD Medical, Inc.
    • 16.3.30. Genesis Medtech
    • 16.3.31. Lydus Medical
    • 16.3.32. Riverpoint Medical
    • 16.3.33. Able Medical Devices Inc.

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. SURGICAL SUTURE MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL SURGICAL SUTURE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL SURGICAL SUTURE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL SURGICAL SUTURE MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL SURGICAL SUTURE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. SURGICAL SUTURE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. SURGICAL SUTURE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. SURGICAL SUTURE MARKET: RESEARCHAI
  • FIGURE 26. SURGICAL SUTURE MARKET: RESEARCHSTATISTICS
  • FIGURE 27. SURGICAL SUTURE MARKET: RESEARCHCONTACTS
  • FIGURE 28. SURGICAL SUTURE MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. SURGICAL SUTURE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SURGICAL SUTURE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL SUTURE MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL SUTURE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL SUTURE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NATURAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NATURAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL SUTURE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL SUTURE MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ABSORBABLE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NON ABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NON ABSORBABLE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MONOFILAMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MONOFILAMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MULTIFILAMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MULTIFILAMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING (CABG), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING (CABG), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL SUTURE MARKET SIZE, BY HEART VALVE REPAIR/REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL SUTURE MARKET SIZE, BY HEART VALVE REPAIR/REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL SUTURE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL SUTURE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CATARACT SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CATARACT SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CORNEAL TRANSPLANTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CORNEAL TRANSPLANTATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FRACTURE FIXATION & LIGAMENT REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FRACTURE FIXATION & LIGAMENT REPAIR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL SUTURE MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL SUTURE MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BREAST RECONSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BREAST RECONSTRUCTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL SUTURE MARKET SIZE, BY COSMETIC PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL SUTURE MARKET SIZE, BY COSMETIC PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL SUTURE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL SUTURE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL SUTURE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL SUTURE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL SUTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL SUTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. AMERICAS SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 78. AMERICAS SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 79. AMERICAS SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 80. AMERICAS SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 81. AMERICAS SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 82. AMERICAS SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 83. AMERICAS SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 84. AMERICAS SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 85. AMERICAS SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 86. AMERICAS SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 87. AMERICAS SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 89. AMERICAS SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 97. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 98. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 99. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 100. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 101. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 102. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 103. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 105. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 106. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 107. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 108. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 109. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 110. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 111. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 112. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 113. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 114. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 117. CANADA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 118. CANADA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 119. CANADA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 120. CANADA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 121. CANADA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 122. CANADA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 123. CANADA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. CANADA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 125. CANADA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 126. CANADA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 127. CANADA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 128. CANADA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 129. CANADA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 130. CANADA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 131. CANADA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 132. CANADA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 133. CANADA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 134. CANADA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 135. MEXICO SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 136. MEXICO SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 137. MEXICO SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 138. MEXICO SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 139. MEXICO SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 140. MEXICO SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 141. MEXICO SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. MEXICO SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 143. MEXICO SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 144. MEXICO SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 145. MEXICO SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 146. MEXICO SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 147. MEXICO SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 148. MEXICO SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 149. MEXICO SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 150. MEXICO SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 151. MEXICO SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 152. MEXICO SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 153. BRAZIL SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 154. BRAZIL SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 155. BRAZIL SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 156. BRAZIL SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 157. BRAZIL SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 158. BRAZIL SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 159. BRAZIL SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. BRAZIL SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 161. BRAZIL SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 162. BRAZIL SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 163. BRAZIL SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 164. BRAZIL SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 165. BRAZIL SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 166. BRAZIL SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 167. BRAZIL SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 168. BRAZIL SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 169. BRAZIL SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 170. BRAZIL SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 171. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 172. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 173. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 174. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 175. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 176. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 177. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 179. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 180. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 181. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 182. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 183. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 184. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 185. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 186. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 187. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 188. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 209. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 210. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 211. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 212. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 213. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 214. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 215. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 217. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 218. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 219. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 220. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 221. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 222. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 223. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 224. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 225. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 227. GERMANY SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 228. GERMANY SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 229. GERMANY SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 230. GERMANY SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 231. GERMANY SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 232. GERMANY SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 233. GERMANY SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. GERMANY SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 235. GERMANY SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 236. GERMANY SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 237. GERMANY SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 238. GERMANY SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 239. GERMANY SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 240. GERMANY SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 241. GERMANY SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 242. GERMANY SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 243. GERMANY SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 244. GERMANY SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 245. FRANCE SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 246. FRANCE SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 247. FRANCE SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 248. FRANCE SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 249. FRANCE SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 250. FRANCE SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 251. FRANCE SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. FRANCE SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 253. FRANCE SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 254. FRANCE SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 255. FRANCE SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 256. FRANCE SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 257. FRANCE SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 258. FRANCE SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 259. FRANCE SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 260. FRANCE SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 261. FRANCE SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 262. FRANCE SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 263. RUSSIA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 264. RUSSIA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 265. RUSSIA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 266. RUSSIA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 267. RUSSIA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 268. RUSSIA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 269. RUSSIA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. RUSSIA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 271. RUSSIA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 272. RUSSIA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 273. RUSSIA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 274. RUSSIA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 275. RUSSIA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 276. RUSSIA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 277. RUSSIA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 278. RUSSIA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 279. RUSSIA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 280. RUSSIA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 281. ITALY SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 282. ITALY SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 283. ITALY SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 284. ITALY SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 285. ITALY SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 286. ITALY SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 287. ITALY SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. ITALY SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 289. ITALY SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 290. ITALY SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 291. ITALY SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 292. ITALY SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 293. ITALY SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 294. ITALY SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 295. ITALY SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 296. ITALY SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 297. ITALY SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 298. ITALY SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 299. SPAIN SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 300. SPAIN SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 301. SPAIN SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 302. SPAIN SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 303. SPAIN SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 304. SPAIN SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 305. SPAIN SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. SPAIN SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 307. SPAIN SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 308. SPAIN SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 309. SPAIN SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 310. SPAIN SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 311. SPAIN SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 312. SPAIN SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 313. SPAIN SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 314. SPAIN SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 315. SPAIN SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 316. SPAIN SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 325. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 326. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 327. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 328. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 329. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 330. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 331. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 332. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 333. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 334. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 335. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 336. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 337. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 338. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 339. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 340. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 341. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 342. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 343. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 344. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY CARDIAC S